ResMed Inc. (RMD)
ResMed Statistics
Share Statistics
ResMed has 146.87M shares outstanding. The number of shares has increased by -0.2% in one year.
| Shares Outstanding | 146.87M |
| Shares Change (YoY) | -0.2% |
| Shares Change (QoQ) | -0.09% |
| Owned by Institutions (%) | 58.82% |
| Shares Floating | 145.63M |
| Failed to Deliver (FTD) Shares | 38 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 8.04M, so 5.48% of the outstanding shares have been sold short.
| Short Interest | 8.04M |
| Short % of Shares Out | 5.48% |
| Short % of Float | 5.52% |
| Short Ratio (days to cover) | 9.87 |
Valuation Ratios
The PE ratio is 26.92 and the forward PE ratio is 24.16. ResMed 's PEG ratio is 2.01.
| PE Ratio | 26.92 |
| Forward PE | 24.16 |
| PS Ratio | 5.87 |
| Forward PS | 4.9 |
| PB Ratio | 5.65 |
| P/FCF Ratio | 21.37 |
| PEG Ratio | 2.01 |
Enterprise Valuation
ResMed Inc. has an Enterprise Value (EV) of 33.42B.
| EV / Earnings | 32.73 |
| EV / Sales | 7.13 |
| EV / EBITDA | 21.79 |
| EV / EBIT | 25.32 |
| EV / FCF | 25.98 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.59 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.18 |
| Total Debt / Capitalization | 15.23 |
| Cash Flow / Debt | 1.6 |
| Interest Coverage | 28.88 |
Financial Efficiency
Return on equity (ROE) is 0.21% and return on capital (ROIC) is 18.57%.
| Return on Equity (ROE) | 0.21% |
| Return on Assets (ROA) | 0.15% |
| Return on Capital (ROIC) | 18.57% |
| Revenue Per Employee | 469.47K |
| Profits Per Employee | 102.30K |
| Employee Count | 9.98K |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.47 |
Taxes
| Income Tax | 243.85M |
| Effective Tax Rate | 0.19 |
Stock Price Statistics
The stock price has increased by 29.21% in the last 52 weeks. The beta is 0.7, so ResMed 's price volatility has been higher than the market average.
| Beta | 0.7 |
| 52-Week Price Change | 29.21% |
| 50-Day Moving Average | 238.68 |
| 200-Day Moving Average | 228.89 |
| Relative Strength Index (RSI) | 44.96 |
| Average Volume (20 Days) | 869.68K |
Income Statement
In the last 12 months, ResMed had revenue of 4.69B and earned 1.02B in profits. Earnings per share was 6.94.
| Revenue | 4.69B |
| Gross Profit | 2.66B |
| Operating Income | 1.32B |
| Net Income | 1.02B |
| EBITDA | 1.53B |
| EBIT | 1.32B |
| Earnings Per Share (EPS) | 6.94 |
Balance Sheet
The company has 238.36M in cash and 873.93M in debt, giving a net cash position of -635.57M.
| Cash & Cash Equivalents | 238.36M |
| Total Debt | 873.93M |
| Net Cash | -635.57M |
| Retained Earnings | 4.99B |
| Total Assets | 7.14B |
| Working Capital | 1.98B |
Cash Flow
In the last 12 months, operating cash flow was 1.40B and capital expenditures -114.86M, giving a free cash flow of 1.29B.
| Operating Cash Flow | 1.40B |
| Capital Expenditures | -114.86M |
| Free Cash Flow | 1.29B |
| FCF Per Share | 8.75 |
Margins
Gross margin is 56.67%, with operating and profit margins of 28.17% and 21.79%.
| Gross Margin | 56.67% |
| Operating Margin | 28.17% |
| Pretax Margin | 27% |
| Profit Margin | 21.79% |
| EBITDA Margin | 32.73% |
| EBIT Margin | 28.17% |
| FCF Margin | 27.46% |
Dividends & Yields
RMD pays an annual dividend of $2.12, which amounts to a dividend yield of 0.9%.
| Dividend Per Share | $2.12 |
| Dividend Yield | 0.9% |
| Dividend Growth (YoY) | 10.42% |
| Payout Ratio | 25.06% |
| Earnings Yield | 2.98% |
| FCF Yield | 3.76% |
Analyst Forecast
The average price target for RMD is $260, which is 11.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $260 |
| Price Target Difference | 11.6% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
Stock Splits
The last stock split was on Aug 31, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 31, 2010 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 13.76 |
| Piotroski F-Score | 9 |